Skip to main content
main-content
Top

Expert commentary: Results from the pediatric medication arm of the RISE trial

Dana Dabelea discusses the RISE investigators’ findings about the physiology of type 2 diabetes in children and the effects of medication on its progression (7:38).

More on this topic